Cancer Network spoke with Marleen Meyers, MD, about evidence on low-dose tamoxifen vs placebo in women who had surgery for their ductal carcinoma in situ.
Marleen Meyers, MD
Advertisement
Articles by Marleen Meyers, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
In Vivo CAR Engineering and the Next Phase of Cellular Immunotherapy
2
3 Things You Should Know About TROP2-Directed Antibody-Drug Conjugates in the Frontline Treatment of Metastatic Triple-Negative Breast Cancer
3
Synchronous Endometrial and Ovarian Cancers: A Case Study and Literature Review
4
TERN-701 Earns FDA Breakthrough Therapy Designation in Ph+ CML
5